Furthermore, we highlighted how the restoration of PRPF31 expression can reverse this phenotype, paving the way for a potential mutation-independent AAV-based gene therapy for the treatment of PRPF31-related RP. Here, PRPF31 is linked to retinitis pigmentosa 1.